# Rosa Rademakers

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rosa-rademakers/

## Facts

| Field | Value |
| --- | --- |
| Citations | 57,293 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 113 |
| i10-index | 382 |
| Last Known Institution | University of Antwerp |
| OpenAlex ID | https://openalex.org/A5048408999 |
| ORCID iD | https://orcid.org/0000-0002-4049-0863 |
| Works | 653 |

## Researcher papers

- [Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS](https://scholariq.org/papers/expanded-ggggcc-hexanucleotide-repeat-in-noncoding-region-of-c9orf72-causes/)
- [Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report](https://scholariq.org/papers/limbic-predominant-age-related-tdp-43-encephalopathy-late-consensus-working/)
- [Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS](https://scholariq.org/papers/mutations-in-prion-like-domains-in-hnrnpa2b1-and-hnrnpa1-cause-multisystem/)
- [Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions](https://scholariq.org/papers/common-variants-at-7p21-are-associated-with-frontotemporal-lobar-degeneration/)
- [Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study](https://scholariq.org/papers/age-at-symptom-onset-and-death-and-disease-duration-in-genetic-frontotemporal/)
- [Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i> -associated amyotrophic lateral sclerosis](https://scholariq.org/papers/poly-gp-proteins-are-a-useful-pharmacodynamic-marker-for-i-c9orf72-i-associated/)
- [CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia](https://scholariq.org/papers/ccnf-mutations-in-amyotrophic-lateral-sclerosis-and-frontotemporal-dementia/)
- [Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS](https://scholariq.org/papers/validation-of-serum-neurofilaments-as-prognostic-and-potential-pharmacodynamic/)
- [Utility of the global CDR<sup>®</sup> plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium](https://scholariq.org/papers/utility-of-the-global-cdr-sup-sup-plus-nacc-ftld-rating-and-development-of/)
- [Temporal order of clinical and biomarker changes in familial frontotemporal dementia](https://scholariq.org/papers/temporal-order-of-clinical-and-biomarker-changes-in-familial-frontotemporal/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Neurological diseases and metabolism](https://scholariq.org/topics/neurological-diseases-and-metabolism/)

## Researcher university

- [University of Antwerp](https://scholariq.org/institutions/university-of-antwerp/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.